Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- EDU +10.4%, NFLX +9.4%, SAP +7.3%, LRN +6.5%, ISRG +6.2%, ASML +5.8%, TEL +4%, ELV +2.7%, TXT +2.2%, SF +1.4%, GD +1.1%, CNI +1% (also increases dividend, announces repurchase of shares under a new normal course issuer bid), IPAR +1%,
Other news:
- KURA +36% (announces oversubscribed $150 million private placement)
- BZUN +6.7% (announces $20 million share repurchase program)
- BITF +5.4% (completed the purchase of land for its new 100 MW production facility in Yguazu Paraguay)
- HRTX +4.5% (receives FDA approval for ZYNRELEF indication expansion to include additional orthopedic and soft tissue procedures)
- EBAY +4% (announced a restructuring plan; expects that its financial results for the quarter will be at least consistent with or in the case of some measures slightly above the higher end of the guidance)
- FHN +3.6% (authorizes $650 mln share repurchase program)
- ROKU +2.8% (in sympathy with NFLX earnings)
- MAG +2.3% (reports Q4 production)
- RIO +2.1% (to drive development of Australia's largest solar power project)
- WBD +1.5% (in sympathy with NFLX earnings)
- LPG +1.2% (announced that its Board of Directors has declared an irregular cash dividend of $1.00 per share of the Company's common stock)
- EXK +1.1% (provides 2024 update for the Terronera Project; initial production remains on schedule for end of 2024)
- PARA +1% (in sympathy with NFLX earnings)
- CACI +1% (wins five-year $382 mln U.S. Army contract)
Analyst comments:
- FIGS +4.3% (upgraded to Equal Weight from Underweight at Barclays)
- ACAD +3.4% (upgraded to Buy from Hold at Needham)
- AMD +2.1% (upgraded to Buy from Neutral at New Street)
- CFB +2% (upgraded to Overweight from Equal-Weight at Stephens)